News
What to Expect From Sierra Wireless' Q2 Earnings Report
Shares of Sierra Wireless (NASDAQ: SWIR) have shot up 90% so far this year as the company has shown a remarkable turnaround in its financial performance of late. The Internet of Things (IoT)
How Risky Is Royal Gold, Inc.?
Precious-metals streaming company Royal Gold, Inc. (NASDAQ: RGLD) makes money by selling gold and silver, but it never gets dirty mining the stuff the way, say, a gold miner does. This changes the
How Risky Is Royal Gold, Inc.?
Precious-metals streaming company Royal Gold, Inc. (NASDAQ: RGLD) makes money by selling gold and silver, but it never gets dirty mining the stuff the way, say, a gold miner does. This changes the
Have Investors Been Overlooking Wheaton Precious Metals?
Investors can get gold and silver exposure in a number of different ways. You can obviously just buy the metals directly, but that often comes with high transaction costs and the need for storage. You
Have Investors Been Overlooking Wheaton Precious Metals?
Investors can get gold and silver exposure in a number of different ways. You can obviously just buy the metals directly, but that often comes with high transaction costs and the need for storage. You
Roundtable: 3 Stocks We Can't Wait to Buy on Sale
The data doesn't lie: High-quality stocks tend to rise in value over the long term. However, that doesn't mean they go up in a straight line. We're investors, and that inherently means we want to buy
The Biggest Risks With Shopify
Shopify (NYSE: SHOP) has grown massively in the past few years, and many analysts think the company has barely scratched the surface of its total addressable market. But like any other company, there
Shopify Is Just Scratching the Surface
Shopify (NYSE: SHOP) investors have been well rewarded in the past few years since the company's IPO, and it shows no signs of slowing down.In this Industry Focus: Tech segment, host Dylan Lewis is
What's Behind Shopify's 175% Surge in the Past 12 Months
Shopify (NYSE: SHOP) is one of the hottest stocks in tech right now, and it's showing no sign of slowing down.In this Industry Focus: Tech segment, host Dylan Lewis is joined by analyst Michael
3 Top Gold Mining Stocks to Buy in 2017
Gold prices may have edged 7% higher so far this year, but several gold mining stocks have lagged behind the yellow metal by a substantial margin. Prudent investors should consider this mismatch an
3 Top Gold Mining Stocks to Buy in 2017
Gold prices may have edged 7% higher so far this year, but several gold mining stocks have lagged behind the yellow metal by a substantial margin. Prudent investors should consider this mismatch an
Cameco Corporation: The Bear Case From a Bull
Cameco Corporation (NYSE: CCJ) is the world's largest pure-play uranium miner. That hasn't been a great business to be in lately, but the outlook for uranium appears pretty enticing. For aggressive
Cameco Corporation: The Bear Case From a Bull
Cameco Corporation (NYSE: CCJ) is the world's largest pure-play uranium miner. That hasn't been a great business to be in lately, but the outlook for uranium appears pretty enticing. For aggressive
Fiat Chrysler Automobiles: Profit Up 15%, Debt Still High
Fiat Chrysler Automobiles (NYSE: FCAU) said its second-quarter operating profit rose 15% to 1.87 billion euros ($2.19 billion) on improved margins in North America and strong results for its luxury
Fiat Chrysler Automobiles: Profit Up 15%, Debt Still High
Fiat Chrysler Automobiles (NYSE: FCAU) said its second-quarter operating profit rose 15% to 1.87 billion euros ($2.19 billion) on improved margins in North America and strong results for its luxury
Fire and Other Operational Items Bite Into Suncor Energy's Earnings... Again
Suncor Energy (NYSE: SU) can't seem to catch a break when it comes to its oil-sands operations. Last year, there was the devastating effect of wildfires in Alberta. This year's fire at its Syncrude
Fire and Other Operational Items Bite Into Suncor Energy's Earnings... Again
Suncor Energy (NYSE: SU) can't seem to catch a break when it comes to its oil-sands operations. Last year, there was the devastating effect of wildfires in Alberta. This year's fire at its Syncrude
Better Buy: Franco-Nevada Corporation vs. GoldCorp
During the 2007-2009 recession, gold went up 25% while the S&P 500 fell a painful 36%. That's why many investors seek some exposure to precious metals. If owning bullion isn't your thing, then key
Better Buy: Franco-Nevada Corporation vs. GoldCorp
During the 2007-2009 recession, gold went up 25% while the S&P 500 fell a painful 36%. That's why many investors seek some exposure to precious metals. If owning bullion isn't your thing, then key
Goldcorp – Das muss jetzt endlich ‘was werden! Sonst …
Gestern gab der Minenmarkt nach dem FED-Statement wieder ein größeres Lebenszeichen von sich. Der HUI-Index legte mit über 3% zu stark zu wie zuletzt Anfang Juni. Auch das HUI-Schwergewicht....
Goldcorp – Das muss jetzt endlich ‘was werden! Sonst …
Gestern gab der Minenmarkt nach dem FED-Statement wieder ein größeres Lebenszeichen von sich. Der HUI-Index legte mit über 3% zu stark zu wie zuletzt Anfang Juni. Auch das HUI-Schwergewicht....
2 Reasons TerraForm Power Inc Stock Could Rise
TerraForm Power Inc (NASDAQ: TERP) has been through a lot in the past two years. It survived the bankruptcy of its sponsor, SunEdison, and after months of uncertainty, Brookfield Asset Management
2 Reasons TerraForm Power Inc Stock Could Rise
TerraForm Power Inc (NASDAQ: TERP) has been through a lot in the past two years. It survived the bankruptcy of its sponsor, SunEdison, and after months of uncertainty, Brookfield Asset Management
An Exciting New Drug Is in Clinical Trials for Aspreva Pharmaceuticals
Richard Glickman was the CEO of Aspreva Pharmaceuticals, which put out CellCept, a drug that treats patient with lupus who develop kidney disease. Glickman has moved on to Aurinia Pharmaceuticals
An Exciting New Drug Is in Clinical Trials for Aurinia Pharmaceuticals
Richard Glickman was the CEO of Aspreva Pharmaceuticals, which put out CellCept, a drug that treats patient with lupus who develop kidney disease. Glickman has moved on to Aurinia Pharmaceuticals